(Q26852081)

English

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

scientific article

In more languages

Statements

scholarly article

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

consensus development conference proceedings

1 reference

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis (English)

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

psoriatic arthritis

1 reference

20 May 2022

rheumatoid arthritis

1 reference

30 June 2019

ankylosing spondylitis

1 reference

30 June 2019

biological products

1 reference

Emilio Monte-Boquet

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Raimon Sanmarti

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Paloma Vela Casasempere

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Isidoro González-Álvaro

1

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Carmen Martínez-Fernández

2

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Benito Dorantes-Calderón

3

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Rosario García-Vicuña

4

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Blanca Hernández-Cruz

5

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Alicia Herrero-Ambrosio

6

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Olatz Ibarra-Barrueta

7

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Emilio Martín-Mola

8

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Alberto Morell-Baladrón

10

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Jesús Sanz-Sanz

12

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Francisco Javier de Toro-Santos

13

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

José Andrés Román Ivorra

15

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

José Luis Poveda-Andrés

16

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Santiago Muñoz-Fernández

17

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Spanish Rheumatology Society

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Spanish Rheumatology Society

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

1 reference

publication date

19 December 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 July 2015

1 reference

20 May 2022

number of pages

10

1 reference

based on heuristic

inferred from page(s)

7 references

12 March 2019

13 March 2019

17 June 2019

30 June 2019

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

20 May 2022

54

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1200-1209

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

7

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

5 references

Europe PubMed Central

12 March 2019

Europe PubMed Central

13 March 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

30 June 2019

Europe PubMed Central

20 May 2022

Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

7 April 2017

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

7 April 2017

Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

7 April 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

7 April 2017

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

7 April 2017

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

7 April 2017

Low- versus high-dose rituximab for rheumatoid arthritis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

How important is early therapy in axial spondyloarthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Increased mortality in ankylosing spondylitis is related to disease activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Mortality in rheumatoid arthritis: 2008 update.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Mortality, course of disease and prognosis of patients with ankylosing spondylitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

The burden of musculoskeletal diseases in the general population of Spain: results from a national survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Psoriatic arthritis. Historical background and epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 September 2017

Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

31 May 2018

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

31 May 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

31 May 2018

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Effectiveness of a clinical practice intervention in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Safety of rituximab in rheumatoid arthritis: a long-term prospective single-center study of gammaglobulin concentrations and infections

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Reduced-dose rituximab in rheumatoid arthritis: efficacy depends on degree of B cell depletion.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

21 January 2018

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 November 2018

Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 November 2018

Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 November 2018

Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 November 2018

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4473767

28 November 2018

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death

2 references

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU461

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating rheumatoid arthritis early: a window of opportunity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of etanercept in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Work Disability in Patients with Ankylosing Spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of s

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/RHEUMATOLOGY/KEU461

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

release_zahlbcfky5fanhmtjlw3unyfyi

1 reference

https://api.fatcat.wiki/v0/release/zahlbcfky5fanhmtjlw3unyfyi

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25526976%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26852081&oldid=1979896301"